Revenue Recognition and Collaborative Arrangements (Tables)

9 Months Ended

Sep. 30, 2018

Revenue Recognition and Collaborative Arrangements

Schedule of revenue from collaborative arrangements

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
(In thousands)	2018		2017		2018		2017
Royalties from a related party - RELVAR/BREO	$	51,745	$	44,604	$	155,420	$	137,938
Royalties from a related party - ANORO		9,769		7,274		29,149		19,464
Royalties from a related party - TRELEGY		3,622		—		6,945		—
Total royalties from a related party		65,136		51,878		191,514		157,402
Less: amortization of capitalized fees paid to a related party		(3,456)		(3,456)		(10,368)		(10,368)
Royalty revenue		61,680		48,422		181,146		147,034
Strategic alliance - MABA program license		—		221		—		663
Total net revenue from GSK	$	61,680	$	48,643	$	181,146	$	147,697